ERS International Congress 2022: highlights from the Thoracic Oncology Assembly.
ERJ Open Res
; 9(4)2023 Jul.
Article
en En
| MEDLINE
| ID: mdl-37583965
ABSTRACT
Thoracic malignancies are associated with a substantial public health burden. Lung cancer is the leading cause of cancer-related mortality worldwide, with significant impact on patients' quality of life. Following 2â
years of virtual European Respiratory Society (ERS) Congresses due to the COVID-19 pandemic, the 2022 hybrid ERS Congress in Barcelona, Spain allowed peers from all over the world to meet again and present their work. Thoracic oncology experts presented best practices and latest developments in lung cancer screening, lung cancer diagnosis and management. Early lung cancer diagnosis, subsequent pros and cons of aggressive management, identification and management of systemic treatments' side-effects, and the application of artificial intelligence and biomarkers across all aspects of the thoracic oncology pathway were among the areas that triggered specific interest and will be summarised here.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Guideline
Aspecto:
Patient_preference
Idioma:
En
Revista:
ERJ Open Res
Año:
2023
Tipo del documento:
Article
País de afiliación:
Portugal